Our News on Newswise

Newswise: 2020-111-11croft.png

New study points to a better way to ward off asthma triggers

While quick-acting inhalers and medications can reduce inflammation during an asthma attack, people with asthma have few tools to prevent the next attack from coming. Now researchers at La Jolla Institute for Immunology (LJI) have discovered that...
11-Nov-2020 3:25 PM EST Add to Favorites

Newswise: 2020Shresta_Zika.png

Fighting Zika? Call in the T cells

In a new Science Advances study, Shresta and her colleagues at LJI report that the immune system's T cells have the power to prevent Zika infection in mice. This finding suggests that effective Zika vaccines need to activate T cells to work...
30-Oct-2020 1:35 PM EDT Add to Favorites

Newswise: diabetes_study.png

Diabetes researchers spot dangerous T cells in the pancreas—even in healthy people

It's long been thought that having "autoreactive" T cells in the pancreas was a sure sign of type 1 diabetes. Yet a new study led by scientists at La Jolla Institute for Immunology (LJI) shows that even healthy people have these cells lurking in the...
12-Oct-2020 4:25 PM EDT Add to Favorites

Newswise: 49557550751_c1f7f420b5_o.jpg

Every COVID-19 case seems different. These scientists want to know why.

A new international study led by scientists at La Jolla Institute for Immunology (LJI), The University of Liverpool and the University of Southampton is the first to give a detailed snapshot of how the body's CD4+ T cells respond to the SARS-CoV-2...
6-Oct-2020 2:40 PM EDT Add to Favorites

Newswise: lungs.png

A step toward helping patients breathe deeply

In a new study, researchers at La Jolla Institute for Immunology (LJI) report that a protein called TL1A drives fibrosis in several mouse models, triggering tissue remodeling, and making it harder for lungs and airways to function normally.
24-Sep-2020 3:35 PM EDT Add to Favorites

Newswise: GraphicalAbstractv18Crotty.jpg

T cells take the lead in controlling SARS-CoV-2 and reducing COVID-19 disease severity

A multi-layered, virus-specific immune response is important for controlling SARS-CoV-2 during the acute phase of the infection and reducing COVID-19 disease severity, with the bulk of the evidence pointing to a much bigger role for T cells than...
16-Sep-2020 2:55 PM EDT Add to Favorites

Newswise: Lindestam-Arlehamn.jpg

LJI scientists receive $3.5 million to investigate role of immune cells in Parkinson's disease

Scientists at the La Jolla Institute for Immunology (LJI) have received $3.5 million as part of a team award from Aligning Science Across Parkinson’s (ASAP) to support a three-year study into how immune cells may contribute to Parkinson's disease.
15-Sep-2020 1:45 PM EDT Add to Favorites

Beating HIV and COVID-19 may depend on tweaking vaccine molecules

In a new Immunity study, researchers at La Jolla Institute for Immunology (LJI) show that one way to improve the body's immune response to vaccines is to factor in antigen valency. Valency refers to the number of antibody binding sites on an antigen.
27-Aug-2020 3:45 PM EDT Add to Favorites


See All News

Our Experts on Newswise

Newswise: EricaSaphire-139_p.jpg

Expert available to discuss Lassa virus and antibody therapies against the virus

26-Nov-2019 10:40 AM EST

Newswise: 2018Dr.MatthiasvonHerrath.jpg

Dr. Matthias von Herrath named world’s leading type 1 diabetes expert

Dr. Matthias von Herrath, M.D., who founded the Type 1 Diabetes Center at La Jolla Institute for Immunology (LJI) has been identified as the world’s top expert in Type 1 Diabetes by Expertscape, an organization that provides tools to quickly and...
12-Dec-2018 11:05 AM EST

See All Experts

Our YouTube Videos

About

The La Jolla Institute for Immunology is dedicated to increasing knowledge and improving human health through studies of the immune system. Our essential purpose is to expand our understanding of how the immune system works and to discover the causes of immune system disorders. The knowledge gained through our biomedical research can, in turn lead to the prevention, treatment and cure of a wide range of human diseases.

Experts

Contacts

Gina Kirchweger
Chief Communications Officer
allergy immunology

gina@lji.org

858-752-6640

Jenna Hambrick
Digital Strategist

jhambrick@lji.org

858.752.6645

Madeline McCurry-Schmidt
Science Writer

madeline@lji.org

619-438-2382

Twitter

close
0.58924